DMAA

10.9000.00%
RB

Roger Bendelac

Chief Executive Officer

Mr. Roger Bendelac is Chief Executive Officer of Drugs Made In America Acquisition Corp. from February 28, 2026. Mr. Bendelac is Chief Executive Officer of Drugs Made In America Acquisition II Corp. from February 28, 2026. He has many years of experience in investment banking, capital markets and corporate advisory services. Since 2015, Mr. Bendelac has also engaged in corporate advisory and investment activities through multiple advisory entities under his direction, providing services in capital formation, mergers and acquisitions, public company structuring and cross-border transactions. Since September 2025, he has served as a consultant with Silverbear Inc., a corporate business consulting firm. He has also served as a director for Apex AI Solutions Limited, an artificial intelligence applications and technology company since September 2025. Since April 2023, Mr. Bendelac has served as secretary of RB Consulting Group Ltd. a corporate consulting firm. Starting in March, 2018, he was appointed and has continued to serve as a director for Opencap Global Inc. He is also a business consultant and has served as president and director of SP Associates Corp., a management consulting and corporate advisory services firm since March 2016.

公司職務